Showing results (131-140 of 482) with videos related to
Sort By:
Pageof 49
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of deathAnthony V D'Amico, Ming-Hui Chen, Andrew A Renshaw, et al.International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapyRonald C Chen, Natalia Sadetsky, Ming-Hui Chen, et al.Lifetime Data Analysis|July 31, 2014
Quantifying the average of the time-varying hazard ratio via a class of transformationsQingxia Chen, Donglin Zeng, Joseph G Ibrahim, et al.BMC Bioinformatics|August 24, 2013
Differential expression analysis with global network adjustmentJonathan A Gelfond, Joseph G Ibrahim, Mayetri Gupta, et al.Acta Biomaterialia|July 4, 2026
Colorectum and embedded networks of nerve fibers present auxetic responses during uniaxial circumferential extensionAmirhossein Shokrani, Atta Seck, Kazunori Hoshino, et al.Statistics in Medicine|January 25, 2023
New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causesMd Tuhin Sheikh, Ming-Hui Chen, Jonathan A Gelfond, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2022
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.Statistica Sinica|January 1, 2019
Bayesian Modeling and Inference for Nonignorably Missing Longitudinal Binary Response Data with Applications to HIV Prevention TrialsJing Wu, Joseph G Ibrahim, Ming-Hui Chen, et al.Journal of the National Cancer Institute|October 11, 2007
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortalityHenry K Tsai, Anthony V D'Amico, Natalia Sadetsky, et al.Clinical Genitourinary Cancer|July 19, 2016
Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at ProstatectomyNeil E Martin, Ming-Hui Chen, Danjie Zhang, et al.Pageof 49